Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005840 | ribosome | 5 | 12 |
GO:0032991 | protein-containing complex | 1 | 12 |
GO:0043226 | organelle | 2 | 12 |
GO:0043228 | non-membrane-bounded organelle | 3 | 12 |
GO:0043229 | intracellular organelle | 3 | 12 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 12 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
GO:1990904 | ribonucleoprotein complex | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 59 | 63 | PF00656 | 0.517 |
CLV_NRD_NRD_1 | 31 | 33 | PF00675 | 0.543 |
CLV_NRD_NRD_1 | 65 | 67 | PF00675 | 0.488 |
CLV_NRD_NRD_1 | 99 | 101 | PF00675 | 0.539 |
CLV_PCSK_KEX2_1 | 20 | 22 | PF00082 | 0.557 |
CLV_PCSK_PC1ET2_1 | 20 | 22 | PF00082 | 0.557 |
DEG_APCC_DBOX_1 | 2 | 10 | PF00400 | 0.555 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.544 |
DOC_MAPK_gen_1 | 17 | 25 | PF00069 | 0.572 |
DOC_MAPK_gen_1 | 32 | 41 | PF00069 | 0.483 |
DOC_PP1_RVXF_1 | 19 | 26 | PF00149 | 0.539 |
DOC_PP1_RVXF_1 | 68 | 74 | PF00149 | 0.315 |
DOC_PP1_RVXF_1 | 98 | 105 | PF00149 | 0.489 |
DOC_USP7_MATH_1 | 40 | 44 | PF00917 | 0.405 |
DOC_USP7_UBL2_3 | 113 | 117 | PF12436 | 0.631 |
DOC_USP7_UBL2_3 | 15 | 19 | PF12436 | 0.548 |
LIG_14-3-3_CanoR_1 | 3 | 9 | PF00244 | 0.558 |
LIG_14-3-3_CanoR_1 | 79 | 83 | PF00244 | 0.494 |
LIG_BIR_III_4 | 62 | 66 | PF00653 | 0.514 |
LIG_FHA_2 | 54 | 60 | PF00498 | 0.472 |
LIG_SH2_STAT5 | 53 | 56 | PF00017 | 0.463 |
LIG_SH2_STAT5 | 80 | 83 | PF00017 | 0.460 |
LIG_SH3_3 | 85 | 91 | PF00018 | 0.534 |
LIG_SH3_3 | 99 | 105 | PF00018 | 0.384 |
LIG_SUMO_SIM_anti_2 | 5 | 10 | PF11976 | 0.554 |
LIG_SUMO_SIM_par_1 | 37 | 44 | PF11976 | 0.423 |
MOD_CK2_1 | 53 | 59 | PF00069 | 0.465 |
MOD_Cter_Amidation | 115 | 118 | PF01082 | 0.661 |
MOD_Cter_Amidation | 64 | 67 | PF01082 | 0.493 |
MOD_GSK3_1 | 40 | 47 | PF00069 | 0.416 |
MOD_NEK2_1 | 2 | 7 | PF00069 | 0.522 |
MOD_NEK2_1 | 61 | 66 | PF00069 | 0.506 |
MOD_NEK2_1 | 83 | 88 | PF00069 | 0.416 |
MOD_NEK2_1 | 93 | 98 | PF00069 | 0.430 |
MOD_PKA_2 | 2 | 8 | PF00069 | 0.560 |
MOD_PKA_2 | 78 | 84 | PF00069 | 0.501 |
MOD_Plk_4 | 4 | 10 | PF00069 | 0.630 |
MOD_Plk_4 | 78 | 84 | PF00069 | 0.501 |
MOD_SUMO_for_1 | 112 | 115 | PF00179 | 0.426 |
MOD_SUMO_for_1 | 54 | 57 | PF00179 | 0.470 |
TRG_ENDOCYTIC_2 | 80 | 83 | PF00928 | 0.484 |
TRG_NLS_Bipartite_1 | 19 | 36 | PF00514 | 0.548 |
TRG_NLS_MonoExtN_4 | 17 | 23 | PF00514 | 0.557 |
TRG_NLS_MonoExtN_4 | 31 | 36 | PF00514 | 0.357 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P2X7 | Leptomonas seymouri | 86% | 100% |
A0A0S4IY48 | Bodo saltans | 73% | 100% |
A0A1X0PA43 | Trypanosomatidae | 86% | 100% |
A0A3R7NLI3 | Trypanosoma rangeli | 81% | 100% |
A0A3S7X845 | Leishmania donovani | 92% | 100% |
A4IA65 | Leishmania infantum | 92% | 100% |
C9ZM42 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 84% | 100% |
E9B577 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
Q4Q2Q8 | Leishmania major | 92% | 100% |
V5BKZ6 | Trypanosoma cruzi | 81% | 100% |